About Biointron:

Founded in  2012
Certified to ISO 9001:2015
High-technology Enterprises
CRO supplier for antibody discovery and expression

Biointron, founded in 2012, is an award-winning international high-tech enterprise based in Shanghai. We specialize in antibody expression, discovery, and optimization. Our mission is to accelerate the antibody discovery process to provide one-stop antibody discovery services. With fully automated production processes adhering to international standards, we've served 1,200+ pharmaceutical companies across 20 countries. Our expertise includes VHH production, hybridoma sequencing, antibody humanization, affinity maturation, and single B cell screening. Biointron has global commercialization reauthorization for ECACC's CHO-K1 cell line and meets international multicenter requirements, which has also been filed with the U.S. FDA's DMF and several partners’ projects have entered the international multicenter clinical stage.

For more information, please visit our official website at www.biointron.com or contact us at info@biointron.com


Biointron

Similar companies